⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MBRX News
Moleculin Biotech, Inc.
Moleculin Announces Grant Funded Research Evaluating Annamycin for the Treatment of Pancreatic Cancer at UNC-Chapel Hill
globenewswire.com
MBRX
Moleculin to Highlight its Ongoing Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial at the 14th Annual Acute Leukemia Meeting
globenewswire.com
MBRX
Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin
globenewswire.com
MBRX
Moleculin Announces Notice of Allowance for Canadian Patent Covering Annamycin
globenewswire.com
MBRX